Display Settings:

Format

Send to:

Choose Destination
Pharmacol Rep. 2005 Sep-Oct;57(5):570-7.

Lipoic acid - the drug of the future?

Author information

  • 1Institute of Medical Biochemistry, Medical College, Jagiellonian University, Kopernika 7, PL 31-034 Kraków, Poland.

Abstract

Numerous experimental and clinical studies proved efficiency of treatment with lipoic acid-containing drugs in diseases, in which pro- and antioxidant balance is disrupted (diabetes, neurodegenerative diseases, acquired immune deficiency syndrome (AIDS), tumors, etc.). Efficiency of lipoate has been attributed to unique antioxidant properties of lipoate/dihydrolipoate system, its reactive oxygen species (ROS) scavenging ability and significant effect on the tissue concentrations of reduced forms of other antioxidants, including one of the most powerful, glutathione (thus lipoate is called an antioxidant of antioxidants). Moreover, analysis of literature data suggests participation of lipoic acid in processes of cell growth and differentiation. This fact can be crucial to clinical practice, however, this problem requires further studies.

PMID:
16227639
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Institute of Pharmacology Polish Academy of Sciences
    Loading ...
    Write to the Help Desk